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Summary. The aim of this study was to determine 
whether subrenal capsule (SRC) implantation is a suit- 
able model for the study of the metastatic potential of 
our human renal cell carcinoma (HRCC) lines and to 
establish new sublines with enhanced metastatic ability. 
NMRI athymic nude mice 7-11 weeks old received SRC 
implantation of our HRCC lines RC43 and RC21. These 
lines were not metastatic when implanted s.c. Mice were 
killed after 4 or 8 weeks, or when moribund. With the 
RC43 cell line the success rate for implantation was 69 %, 
with 89% of these showing metastases. The average 
volume of the implanted tumour fragments was 0.5 mm 3 
(range 0.28-0.7), the average volume at the primary site 
at the time of death was 9087 (9-32000) mm 3. Metastases 
were found in lymph nodes, liver, spleen, peritoneum, 
psoas muscle, pancreas, diaphragm and skin. The aver- 
age volume of the metastases was 4139 (0.5-9000) mm 3. 
Growing cell lines were established in vivo and in vitro 
from one splenic, one peritoneal, one diaphragmatic, and 
one hepatic metastasis. These sublines have faster in vivo 
and slower in vitro growth rates than the parental lines. 
With the RC21 cell line the success rate for implantation 
was 56% and the metastatic rate 78%. The average 
volume of the implanted tumour was 0.8 mm 3 (0.28-1.2), 
the average volume at the primary site at the time of 
death was 2685 mm 3 (1.4-6534) and the average volume 
of metastases was 7.1 mm 3 (0.5-37.5). Metastases were 
found in lymph nodes, lung and skin. No establishment 
was attempted for RC21 because of the small dimensions 
of these metastases. SRC implantation is thus considered 
a useful tool for the study of the metastatic ability of our 
cell lines RC43 and RC21. The establishment of new 
sublines with a faster growth rate and an enhanced 
metastatic ability will be useful for further studies on the 
metastatic process. 
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Cancer patients rarely die of their primary tumours. 
Establishment of metastases in various organs and their 
subsequent growth usually cause the terminal cachexia of 
neoplastic patients. 
The non-random pattern of visceral metastases sug- 
gested to Paget [1] more than 100 years ago that the 
growth of metastases was due to an affinity between 
turnout cells (seeds) and a suitable environment in some 
organs (soil). Since then, the metastatic process has only 
been partially clarified, mainly because of the relative 
scarcity of experimental models that could reliably repro- 
duce the interactions between host and tumour cells. 
Human renal cell carcinoma (HRCC) is an uncommon 
malignancy (6 % of all tumours diagnosed each year) with 
a poor prognosis ranging from 73 to 8 % survival at 5 years 
depending on the stage at diagnosis [2]. The establishment 
of HRCC lines growing in vitro or in vivo is not easy. In 
our laboratory only 10 % of implanted tumours produced 
a serially transplantable line [3]. Furthermore, the simple 
model of an s.c.-growing tumour is not very useful for 
research regarding the metastatic process. None of our cell 
lines gave rise to metastases when implanted s.c. in nude 
mice, whereas all the patients from whom the tumours 
were isolated have since died. 
The aim of this study was to determine whether 
orthotopic implantation under the renal capsule is a 
suitable method for the enhancement of the metastatic 
potential of our in vivo cell lines and to establish new 
sublines with enhanced metastatic ability. 
Materials and methods 
Cell lines 
The two cell lines used, RC43 and RC21, are maintained in our 
laboratory. RC43 is a grade 4 renal celt carcinoma that was isolated 
following s.c. implantation i  nude mice of a surgical specimen from 
a lymph node metastasis. The female patient with a complete staging 
(UICC 1978) pT3N4M0, died 3 month postoperatively because of 
cancer. The doubling time of this cell line is 84 h in vitro and 4 days in 
vivo. 
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Table 1. Comparison of the results of the subrenal capsule (SRC) 
implantation for RC43 and RC21 cell lines 
RC21 RC43 
Mean tumour size at implant (mm 3) 0.8 0.5 
Success rate (%) 55 69 
Metastatic rate (%) 80 89 
Size of metastases (ram 3) 7.2 4139 
Range 0.5-37.5 0.5-9000 
Site of metastases 
Lymph nodes 10 10 
Lung 5 - 
Liver 4 
Spleen 2 
Peritoneum 2 
Skin 1 1 
Diaphragm 1 
Psoas muscle 1 
Pancreas - 1 
Total number of sites 16 22 
RC21 is a grade 3 renal cell carcinoma that was isolated by 
implanting a specimen of a primary tumour from a female patient 
with complete staging pT2NOM1, who died of cancer 11 months 
postoperatively. The doubling time is 55 h in vitro and 5.2 days in 
vivo. Those two lines never esulted in metastases when implanted 
S.C. 
Animals 
NMRI nude mice from our breeding colony were used at 7-11 weeks 
old. The age of the mice was chosen to avoid the effects of low 
activity of natural killer cells, which is known to influence the 
expression of metastatic potential [4]. Mice were kept in a laminar 
flow cabinet hroughout the experiments under specific pathogen- 
free conditions with free access to food and water. 
SRC implant 
The technique described by Bogden et al. [5] was used. Tumours 
were mechanically minced under a stereoscopic microscope inorder 
to obtain fragments with average volume of approximately 0.5 mm 3 
(L X W2/2; L = length, W = width) as measured with a calibrated 
ocular micrometer. 
The use of this technique minimizes the spilling of tumour cells 
from the implant site, which is possible when using a cell suspension 
for the implant. Mice, anaesthetized with 0.4 ml, tribromoethano] 
(Aldrich, Beerse, Belgium) i.p. were placed in the left lateral 
decubitus and the left kidney was exposed through a vertical flank 
incision. After a horizontal incision in the translucent kidney, 
capsule, the tumour fragment was introduced beneath the renal 
capsule, using a 16-gauge trocar needle. The wound was closed in 
one layer with a 5/0 silk suture. 
Mice were killed at 4 and 8 weeks from the time of implantation, 
or when moribund. At autopsy the size of the turnout at the primary 
site was measured together with the size and location of macroscopi- 
cally evident metastases. These were, when possible, removed in a 
sterile way to facilitate further growth in vitro and/or in vivo. 
Thoracic and abdominal organs were fixed in 10% formalin and 
processed for histological examination. 
The growth rate in vivo was determined by caliper measurements 
of L and W of the SC implant every 3 days, using the formula for 
volume, V, [6]: 
V = 0.52(L • W) 3/z 
The growth rate in vitro was determined by means of the MTT assay 
[7]. Differences were analysed for statistical significance by use of 
the ~ test. 
Results 
RC43 ceil line 
Growth was seen in 9 out of 13 evaluable nude mice 
(Success rate 69%); of these, 89% showed metastases 
(metastat ic rate). The mean volume of the tumour  at the 
implantat ion site was 9087 mm 3 (range 9-32000). The 
average volume of metastases was 4139 mm 3 (0.5-9000). 
Metastases were located (Table 1) in the lymph nodes (10), 
liver (4), spleen (2), per i toneum (2), contralateral  psoas 
muscle (1), pancreas (1), skin (1) and d iaphragm (1). No 
metastases were found in the lungs. No mice survived up 
to week 8 after implantat ion,  all becoming cachectic 
within week 7. 
RC21 cell line 
The success rate for implantat ion was 55 % (10 out of  18 
evaluable). Metastat ic rate was 80%. The average volume 
at the pr imary  site was 2685 mm 3 (1.4-6534) and the 
average volume at the metastat ic locat ion was 7.2 mm 3 
(0.5-37.5). Metastases were situated in the lymph nodes 
(10), lung (5) and skin (1). Only 30% of mice survived 8 
weeks from implantat ion.  
Establishment of new sublines 
Four  new sublines were established, derived from RC43 
metastases. No sublines were isolated from RC21 because 
of the small dimensions of the metastases. 
The RC43MSP subline was isolated from a splenic 
metastasis. It is mainta ined in vitro, with a doubl ing t ime 
of 100 h and in vivo, by SC implant,  with a doubl ing time 
of 3 days. The RC43MLI  subline was isolated from a liver 
metastasis and has a doubl ing time of 105 h in vitro and 
2.5 days in vivo. RC43MDI  was isolated from a diaphrag-  
matic metastasis with a doubl ing time of  95 h in vitro and 
2.5 days in vivo. RC43MBO was isolated from a colon 
metastasis and shows a doubl ing time of 100 h in vitro and 
3 days in vivo. 
As shown in Fig, 1, all these sublines exhibited a faster 
growth rate in vivo than the parental  RC43, while they 
have a slower growth rate in vitro (P of RC43 vs MSP = 
0.002, vs MBO = 0.004, vs ML I  = <0.01, vs MDI  = 
0.001). 
No histological changes were evident; these sublines 
remained G4 renal cell carc inoma s the parental  RC43. 
When re implanted in the SRC, all sublines spread fast, 
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Fig. 1. Comparison of in vivo growth rates of 
RC43 and its sublines MSP, MDI, MLI and 
MBO 
Table2. Comparison of the results of (SRC) implantation for the 
sublines MBO, MSP, MDI, MLI 
MSP MBO MDI MLI 
Mean tumour size at implant (ram 3) 0.6 1.2 1 1.1 
Success rate (%) 100 100 100 100 
Metastatic rate (%) 100 100 100 100 
Total number of metastases 99* 97* 98* 149" 
*P-value for difference from RC43 parental line = 0.001 
which further educed the survival time of the mice (Table 
2). Site specificity of these sublines with respect to 
metastases is under investigation. 
Discussion 
As previously stated, metastases are the most probable 
cause of death in cancer patients. The metastatic process 
has been only partially clarified. It is now known to be a 
multistep rocess involving neovascularization, i vasion 
of the venules, capillaries and lymphatics, embolization, 
arrest in a distant capillary district, adherence to the 
endothelial cells, extravasation and, finally, tumour cell 
proliferation [8]. 
The study of these different steps requires experimental 
models that reproduce physiological conditions occuring 
in the human. After SC turnout implantation, a fibrous 
capsule surrounding the tumour is seen as part of the 
reaction of the host animal [3], while local immune factors 
also play a role in initiating or inhibiting the metastatic 
cascade. The SRC assay was first described by Bogden [5, 
9, 10], who used this method for testing the sensitivity of 
tumours of various origins to different chemotherapeutic 
agents. Following SRC implantation o fibrous capsule is 
formed by the animal [3] and the vascularization at the site 
of the implant seems to aid full expression of the 
metastatic ability of the cells [8]. 
Recently the concept hat orthotopic implantation is
essential for selection, growth and formation of metas- 
tases was suggested by Fidler and Naito [11] for HRCC 
and by other authors for different umour systems [12- 
17]. 
From analysis of our results, no statistically significant 
difference was found between the absolute number of 
colonies in the two different cell lines (P = 0.25). In 
contrast, the difference in size of the tumour at the 
implantation site at the time of death (P = 0.005) and the 
difference in size of the metastatic lesions (P = 0.001) are 
highly significant and favour the RC43-derived metas- 
tases. 
This difference can only be partially ascribed to the 
faster growth rate of RC43 compared to RC21. Whereas 
the average tumour volume at the primary site is only 3 
times larger for RC43, a 100-fold difference was observed 
for the average volume of metastases. Observing the 
localization of metastases, it is interesting to note that 
while RC21 favours lung colonization, RC43 shows wide 
colonization of abdominal organs and of the liver. This 
difference could be due to a different route of metastases: 
haematogenous for RC21 and via the lymphatics for 
RC43, particularly as RC43 was originally isolated from a 
lymph node metastasis. 
The sublines that we have isolated have some interest- 
ing characteristics. By flow cytometry (data not shown) a 
difference in the ploidy pattern between at least wo of the 
sublines (MSP and MDI) and the parental RC43 was 
observed. The observation that growth was faster in vivo 
and slower in vitro for all sublines with respect o the 
parental RC43 cell line also strongly supports in their 
origin from different clones of the four sublines. 
We conclude that SRC implantation is a useful tool for 
the evaluation of the metastatic potential of our in vivo 
cell lines, RC43 nd RC21. With the SRC implantation it is 
also possible to establish new sublines, allowing ex- 
pression of the intrinsic clonal heterogeneity of HRCC. 
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The enhanced metastatic ability can be used for further 
research on metastatic processes. 
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